| Biotechnology
Industry |
|
Process
Biotechnology |
Peptide
synthesis: chemical or enzymatic
Fanny Guzmán
Instituto
de Biología
Pontificia Universidad Católica de Valparaíso
Avenida Brasil 2950
Valparaíso, Chile
Fax: 56 32 212746
E-mail: fanny.guzman@ucv.cl
Sonia
Barberis
Facultad de Química, Bioquímica y Farmacia
Universidad Nacional de San Luis
Ejército de los Andes 950 (5700)
San Luis, Argentina
E-mail: sbarberi@unsl.edu.ar
Andrés
Illanes*
Escuela de Ingeniería Bioquímica
Pontificia Universidad Católica de Valparaíso
Avenida Brasil 2147
Fax: 56 32 2273803
E-mail: aillanes@ucv.cl
*Corresponding
author
Financial
support: This
work was done within the framework of Project CYTED IV.22 Industrial
Application of Proteolytic Enzymes from Higher Plants.
Keywords:
enzymatic synthesis, peptides, proteases, solid-phase synthesis.
| Abbreviations: |
CD: circular dichroism
CLEC: cross linked enzyme crystals
DDC: double dimer constructs
ESI: electrospray ionization
HOBT: hydroxybenzotriazole
HPLC: high performance liquid hromatography
KCS: kinetically controlled synthesis
MALDI: matrix-assisted laser desorption ionization
MAP: multiple antigen peptide system
MS: mass spectrometry
NMR: nuclear magnetic resonance
SPS: solution phase synthesis
SPPS: solid-phase peptide synthesis
t-Boc: tert-butoxycarbonyl
TCS: thermodynamically controlled synthesis
TFA: trifluoroacetic acid
|
Peptides
are molecules of paramount importance in the fields of health care
and nutrition. Several technologies for their production are now available,
among which chemical and enzymatic synthesis are especially relevant.
The present review pretends to establish a non-biased appreciation
of the advantages, potentials, drawbacks and limitations of both technologies.
Chemical synthesis is thoroughly reviewed and their potentials and
limitations assessed, focusing on the different strategies and challenges
for large-scale synthesis. Then, the enzymatic synthesis of peptides
with proteolytic enzymes is reviewed considering medium, biocatalyst
and substrate engineering, and recent advances and challenges in the
field are analyzed. Even though chemical synthesis is the most mature
technology for peptide synthesis, lack of specificity and environmental
burden are severe drawbacks that can in principle be successfully
overcame by enzyme biocatalysis. However, productivity of enzymatic
synthesis is lower, costs of biocatalysts are usually high and no
protocols exist for its validation and scale-up, representing challenges
that are being actively confronted by intense research and development
in this area. The combination of chemical and enzymatic synthesis
is probably the way to go, since the good properties of each technology
can be synergistically used in the context of one process objective.
|